Millipore Acquires NovAseptic AB: Broadens Offering to Biotech and Pharmaceutical Industry
Millipore Corporation announced that it has completed the acquisition of over 90% of the shares of NovAseptic AB from the company's majority shareholders. Millipore is in the process of acquiring the remaining shares from the minority shareholders.
Martin Madaus, Millipore's Chairman, CEO and President, noted: "NovAseptic brings innovative and differentiated products that our biotech and pharmaceutical customers value highly for manufacturing biologics and for monitoring bio-manufacturing processes. There is a great fit strategically and tactically, and we've added exceptional technology and talent to Millipore."
NovAseptic, based in Gothenburg, Sweden, provides a range of innovative solutions for aseptic processing applications in biotech and pharmaceutical manufacturing operations. NovAseptic's products include a unique disposable sampling system (NovaSeptum(R)) and a range of high-performance mixers, valves, and connectors.
Most read news
Other news from the department business & finance
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
PharmacoDesign Purchases Illumina Genotyping Solutions for Pharmacogenomics Research - Illumina to Gain Exclusive, Licensed Access to Biomarkers Discovered Through Disease Studies
![Signatures of of heart attack - Multi-omics factor analysis provides new insights - Analysed for the first time: How does the immune system react to a heart attack?](https://img.chemie.de/Portal/News/664db37fc2a22_aREGKIAGk.png?tr=w-696,h-522,cm-extract,x-182,y-197:n-xzoom)